(Q44985416)

English

Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Ettore Malacco

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Massimo Santonastaso

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Natale A Varì

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Anna Gargiulo

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Vitaliano Spagnuolo

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Federico Bertocchi

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Paolo Palatini

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril Study

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

855-865

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Compliance with antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in antihypertensive therapy--the role of adverse effects and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II receptor blockers: review of the binding characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of the angiotensin-converting-enzyme inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of AT1 receptor blockade on endothelial function in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute Simultaneous Stimulation of Nitric Oxide and Oxygen Radicals by Angiotensin II in Humans in Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibitors in antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan Reduces Phenylephrine Constrictor Response in Aortic Rings From Spontaneously Hypertensive Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary Kinin Generation Mediates Nitric Oxide Release After Angiotensin Receptor Stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Update: role of the angiotensin type-2 (AT(2)) receptor in blood pressure regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolving strategies for renoprotection: diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The ongoing telmisartan alone and in combination with ramipril global endpoint trial program

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ALLHAT and ANBP2: what have we learned from recent mega-trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990129-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(04)90129-4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44985416&oldid=1400433099"